secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spyre Therapeutics, Inc. (SYRE)
CIK:        0001636282
Form:       8-K
Filed at:   2022-03-18T23:59:59+00:00
Accession:  0001564590-22-010951
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aeglea Bio's VP/Controller Steven Weber resigns; CFO Alspaugh named principal accounting officer
--------------------------------------------------------------------------------

- Steven Weber resigns as VP/Corporate Controller and principal accounting officer, effective March 25, 2022.
- CFO Jonathan Alspaugh appointed principal accounting officer effective March 17, 2022.
- Alspaugh, age 39, has served as CFO since July 2021; prior roles include Managing Director at Evercore.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636282/000156459022010951/0001564590-22-010951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636282/000156459022010951/agle-8k_20220316.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-010951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer